Oral immunization with recombinant helicobacter pyloriurease induces secretory iga antibodies and protects mice from challenge with helicobacter felis

Journal of Infectious Diseases

Volumn 172, Issue 1, 1995, Pages 161-172

  Lee, Cynthia K ^a,b   Weltzin, Richard ^a,b   Thomas, William D ^a,b   Kleanthous, Harold ^a,b   Ermak, Thomas H ^a,b   Seman, Gopalan ^a,b   Hill, Joseph E ^a,b   Ackerman, Samuel K ^a,b   Monath, Thomas P ^a,b  

^a Acambis   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ENZYME; BACTERIAL VACCINE; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MURAMYL DIPEPTIDE DERIVATIVE; RECOMBINANT PROTEIN; SECRETORY IMMUNOGLOBULIN; UREASE;

ANIMAL MODEL; ARTICLE; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; INTRAGASTRIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; SALIVA LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMAL; ANTIBODY FORMATION; BACTERIAL VACCINES; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; FECES; GASTRIC MUCOSA; HELICOBACTER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SALIVA; STOMACH; UREASE; VACCINES, SYNTHETIC;

EID: 0029069313     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/172.1.161     Document Type: Article

References (70)

1. Taylor DN, Parsonnet J. Epidemiology and natural history of Helicobacterpylori infection. In: Blaser MJ, Smith PD, Ravdin J, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1994.
2. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990;161:626-33.
3. Lee A, Fox J, Hazell SL. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 1993;61:1601-10.
4. Scolnick JV, Tompkins LS. Helicobacter pylori and gastroduodenal disease: pathogenesis and host-parasite interaction. Infect Agents Dis 1993;1:294-309.
5. Cover TL, Blaser MJ. Helicobacter pylori and gastroduodenal disease. Annu Rev Med 1992;43:135-45.
6. Forman D, Webb P. Geographic distribution and association with gastric cancer. In: Northfield TC, Mendall M, Goggin PM, eds.Helicobacter pylori infection. Dordrecht, Germany: Kluwer Academic Publishers, 1993:11-20.
7. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.Lancet 1993;2:575-7.
8. Sipponen P. Natural history of gastritis and the relationship to peptic ulcer disease. Digestion 1990;5:70-5.
9. Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359-63.
10. Chen M, Lee A, Hazell SL. Immunization against gastric helicobacter infection in a mousdHelicobacterfelis model. Lancet 1992;339:1120-1.
11. Chen M, Lee A, Hazell SL. Immunization against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer. Zentralbl Mikrobiol 1993;180:155-65.
12. Czinn SJ, Cai A, Nedrud JCI. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993;11:637-42.
13. Davin C, Blum A, Corthesy-Theulaz I, et al. H. pylori urease elicits protection against H. felis infection in mice [abstract]. Gastroenterology 1993; 104:A1035.
14. Michetti P, Corthesy-Theulaz I, Davin C, et al. immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002-11.
15. Thomas WD Jr, Lee CK, Lofsky A, Nichols R, Houle D. Effect of oral immunization with Helicobacter pylori antigens on colonization by Helicobacter felis in mice. Acta Gastroenterol Belg 1993;56:4.
16. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequence of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991;173:1920-31.
17. Hu LT, Foxall PA, Russell R, Mobley HLT. Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB.Infect Immun 1992;60:2657-66.
18. Lee A, Hazell SL, O’Rourke J, Kouprach S. Isolation of a spiral-shaped bacterium from the cat stomach. Infect Immun 1988;56:2843-50.
19. Clayton CL, Pallen MJ, Kleanthous H, Wren BW, Tabaqchali S. Nucleo tide sequence of two genes from Helicobacter pylori encoding for urease subunits. Nucleic Acids Res 1990; 18:362.
20. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JH. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990;185:60-89.
21. Sambrook J, Fritch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
22. Lennette EH, Schmidt NJ. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 5th ed. Washington, DC: American Public Health Association, 1979.
23. Blanchard TG, Czinn SJ, Maurer R, Thomas WD Jr, Soman G, Nedrud JG. Urease specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun 1995;63:1394-9.
24. Garvey W, Fathi A, Bigelow F. Modified Steiner method for the demonstration of spirochetes. J Histotechnol 1985;8:15-7.
25. Lee CK, Weltzin R, Soman G, Georgakopoulos KM, Houle DM, Monath TP. Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice. Infect Immun 1994;62:887-91.
26. Ferrerò RL, Labigne A. Cloning, expression, and sequencing of Helicobacter felis urease genes. Mol Microbiol 1993;9:323-33.
27. Austin JW, Doig P, Stewart M, Trust T. Macromolecular structure and aggregation states of Helicobacter pylori urease. J Bacteriol 1991; 173:5663-7.
28. Xia HX, Keane CT, Omorain CA. Pre-formed urease activity of Helicobacter pylori as determined by a viable cell count technique—clinical implications. J Med Microbiol 1994;40:435-9.
29. Pallen MJ, Clayton CL. Vaccination against Helicobacter pylori urease. Lancet 1990;2:186-7.
30. Hu LT, Mobley HLT. Purification and N-terminal analysis of urease from Helicobacter pylori.Infect Immun 1990;58:992-8.
31. Hawtin PR, Stacey AR, Newell DG. Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies. J Gen Microbiol 1990;136:1995-2000.
32. Eaton KA, Krakowka S. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori.Infect Immun 1994;62:3604-7.
33. Tsuda M, Karita M, Morshed MG, Okita K, Nakazawa T. A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun 1994;62:3586-9.
34. Ferrerò RL, Lee A. The importance of urease in acid protection for the gastric-colonizing bacteria Helicobacter pylori and H. felis sp nov. Microbiol Ecol Health Dis 1991;4:121-34.
35. Ferrerò RL, Labigne A. Cloning, expression, and sequencing of Helicobacter felis urease genes. Mol Microbiol 1993;9:323-33.
36. Gootz TD, Perez-Perez GI, Clancy J, Martin BA, Tait-Kamradt A, Blaser MJ. Immunological and molecular characterization of Helicobacter felis urease. Infect Immun 1994;62:793-8.
37. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990; 99:1315-23.
38. Hemings WA. Antigen absorption in the gut. Lancaster, UK: MTP Press, 1978.
39. Eldridge JH, Hammond CJ, Meulbrook JA, Staas JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer’s patches. J Controlled Release 1990;11:205-14.
40. Ermak TH, Dougherty EP, Bhagat HR, Kabok Z, Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer’s patch M cells. Cell Tissue Res 1995;279:433-6.
41. Kreuter J. Physicochemical characterization of nanoparticles and their potential for vaccine preparation. Vaccine Res 1992;1:93-8.
42. O’Hagan DT, Palin KJ, Davis SS, Artursson P, Sjoholm I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989; 7:421-4.
43. Pappo J, Ebersole JL, Taubman MA. Resident salivary gland macrophages function as accessory cells in antigen-dependent T-cell proliferation. Immunology 1988;63:99-104.
44. Chen M, Lee A. Vaccination possibilities and probabilities, in: Northfield TC, Mendall M, Goggin PM, eds. Helicobacter pylori infection. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:158-67.
45. Eaton KA, Krakowka S. Chronic active gastritis due to Helicobacter pyloriin immunized gnotobiotic piglet. Gastroenterology 1992;103:1580-6.
46. Rathbone BJ, Wyatt JI, Worsley BW. Systemic and local antibody responses to gastric Campylobacterpyloridis in non-ulcer dyspepsia. Gut 1986;27:642-7.
47. Crabtree J, Wyatt J. Host responses. In: Northfield TC, Mendall M, Goggin PM, eds. Helicobacter pylori infection. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:40-52.
48. Crabtree JE, Shallcross TM, Wyatt Ji, et al. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sei 1991;36:1266-73.
49. Kist M. Immunology of Helicobacter pylori. In: Marshall BJ, et al., eds. Helicobacter pylori in peptic ulceration and gastritis. Oxford, UK: Blackwell Scientific Publications, 1991:92 110.
50. Fox JG, Blanco M, Murphy JC, et al. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 1993;61:2309-15.
51. Valnes K, Braentzaeg P, Elgjo K, Stave R. Specific and non-specific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Gastroenterology 1984;86:402-12.
52. Thomas JE, Whatmore AM, Kehow MA, Skillen AW, Barer M. Assay of urease-inhibiting activity in serum from children infected with Helicobacter pylori.J Clin Microbiol 1992;30:1338-40.
53. McNabb PC, Tomasi TB. Host defense mechanisms at mucosal surfaces. Annu Rev Microbiol 1981;35:477-96.
54. Saltzman WM, Radomsky ML, Whaley KJ. Antibody diffusion in human cervical mucus, öiophys J 1994;66:508-15.
55. McSweegan E, Burr DH, Walker RI. Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to TNT 407 cells. Infect Immun 1987;55:1431-5.
56. Caldwell MB, Walker RI, Stewart SD. Development of an adult rabbit model of Campylobacter jejuni infection suitable for testing immune responses to disease. In: Pearson AD, ed. Campylobacter II. London: Public Health Laboratories Service, 1983:119.
57. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium.Infect Immun 1992;60:1786-92.
58. Freier R. Studies on the mechanism of action of intestinal antibody in experimental cholera. Tex Rep Biol Med 1969;27:299-316.
59. Lake AM, Block KJ, Neutra MR. Intestinal goblet cell mucus release. II. In vivo stimulation by antigen in the immunized rat. J Immunol 1979;122:834-7.
60. Newell DG, Stacy A. Antigens for the serodiagnosis of Campylobacterpylori infections. Gastroenterol Clin Biol 1989; 13:37B-41B.
61. Dunn BE, Campbell GP, Perez-Perez G, Blaser MJ. Purification and characterization of urease from Helicobacter pylori.J Biol Chem 1990; 265:9464-9.
62. Levine MM, Black RE, Clements ML, Nalin DR, Cisneros L, Finkelstein RA. Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli.In: Holme T, Holmgren J, Merson M, Mollby R, eds. Acute enteric infection in children: new prospects for treatment and prevention. Amsterdam: Elsevier/North Holland, 1981: 443-59.
63. Tamura SI, Yamanaka A, ShimoharaM, et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994;12:419-25.
64. Wilson AD, Clarke CJ, Stokes CR. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand J Immunol 1990; 31:443 51.
65. Lee A, Chen M. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit whole cell vaccine. Infect Immun 1994;62:3594-7.
66. Clements JD, Hartzog NM, Lyons FL. Adjuvant activity of Escherichiacoli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988;6:269 77.
67. Walker RI, Clements JD. Use of heat-labile toxin of Escherichia coli to facilitate mucosal immunization. Vaccine Res 1993;2:1-10.
68. Andronova T, Ivanov V. The structure and immunomodulating function of glucosaminylmuramyl peptides. Soviet Med Rev D: Immunol 1991;4:1-63.
69. Pappo J, Thomas WD Jr, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995;63:1246-52.
70. Mai UE, Perez-Pcrez GI, Allen JB, Wahl SM, Blaser MJ, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175:517 25.